Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Lymphoma Academic Research Organisation (LYSARC) is the largest European academic organization dedicated to lymphoma research. Functioning as the operational arm of the Lymphoma Study Association (LYSA), LYSARC performs the functions of an Academic Research Organization (ARO) to manage international clinical trials from Phase 1 to Phase 4. The organization provides a comprehensive suite of services including clinical operations, data management, biostatistics, and a centralized pathology and biobank network. By collaborating with pharmaceutical partners and academic institutions, LYSARC aims to improve the treatment and care of patients with all types of lymphoma through high-quality clinical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Lymphoma Academic Research Organisation.